StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 02/15/2013 -- StockRunway.com issues special report on Biotech Stocks – Amgen, Inc. (NASDAQ:AMGN), Dendreon Corporation (NASDAQ:DNDN), Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Amgen, Inc. (NASDAQ:AMGN) recently reported an update on its long-term strategy. The company said that it plans to focus on the discovery and development of molecules that address important unmet medical requirements and the manufacture of biologics.
How Should Investors Trade AMGN Now? Don’t Miss out a Special Trend Analysis
The company is hopeful about the Prolia -Xgeva (denosumab) franchise, which brought combined sales of $1.2 billion in 2012, to post combined sales of more than $3 billion over time.
During the mid-day, Amgen, Inc. (NASDAQ:AMGN) plunged -0.89% to $83.97 with the total traded volume of 2.57 million shares. AMGN has earnings per share of $5.52 and its price to earnings ratio ended at 15.20.
Dendreon Corporation (NASDAQ:DNDN) shares went down after the Maxim Group downgraded the stock from “hold” to “sell.”
What DNDN’s Charts Are Signaling for Traders? Find Out Here
In the mid-day trading hours, Dendreon Corporation (NASDAQ:DNDN) dropped -2.20% to $6.21 with the total traded volume of 2.31 million shares. Stock price 52 weeks high was $15.20 and 52 weeks low price was 3.69. DNDN has market cap of 959.85 million. Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients.
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) jumped +7.59% to $29.49 in the mid-day with the total traded volume of 2.40 million shares. Its fifty two week range was $17.25-$58.91. The total market capitalization remained $1.72 billion.
Can QCOR Show a Strong Recovery? Find out in This Research Report
QCOR is ahead its 52 week low with 74.31% and its last month price volatility remained 3.00%. Its beta coefficient was 0.75 with a target price of $41.86. In its share capital QCOR has 58.45 million outstanding shares while 57.71 million shares have been floated in market. QCOR has insider ownership of 0.36% with its institutional ownership remained 62.58%. Company’s current year earnings per share grew with 122.58% while the five year EPS growth rate was +38.05%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) moved up +0.93% to $8.43 during the mid-day trading hours and its total traded volume was 1.82 million shares. ARNA has outstanding shares of 217.29 million with the total market cap of 1.83 billion and its beta value stands at 0.16 times.
Should ARNA a Buy or Sell Now? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
For more information on this press release visit: http://www.sbwire.com/press-releases/biotech-stocks-to-watch-nasdaqamgn-nasdaqdndn-nasdaqqcor-nasdaqarna-208044.htm